{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:35:10Z","timestamp":1791689710065,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01566-8","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T14:21:20Z","timestamp":1739197280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Bayesian meta-analysis on MRI-based radiomics for predicting EGFR mutation in brain metastasis of lung cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Peyman","family":"Tabnak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zana","family":"Kargar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ebrahimnezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanyar","family":"HajiEsmailPoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"1566_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20:624\u201339.","journal-title":"Nat Rev Clin Oncol"},{"key":"1566_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1566_CR3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3747\/co.20.1481","volume":"20","author":"A Ali","year":"2013","unstructured":"Ali A, Goffin JR, Arnold A, Ellis PM. Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases. Curr Oncol. 2013;20:300\u20136.","journal-title":"Curr Oncol"},{"key":"1566_CR4","doi-asserted-by":"publisher","first-page":"20210944","DOI":"10.1259\/bjr.20210944","volume":"95","author":"SHAE Derks","year":"2022","unstructured":"Derks SHAE, van der Veldt AAM, Smits M. Brain metastases: the role of clinical imaging. Br J Radiol. 2022;95:20210944.","journal-title":"Br J Radiol"},{"key":"1566_CR5","doi-asserted-by":"publisher","first-page":"vdz017","DOI":"10.1093\/noajnl\/vdz017","volume":"1","author":"P Kancharla","year":"2019","unstructured":"Kancharla P, Ivanov A, Chan S, Ashamalla H, Huang RY, Yanagihara TK. The effect of brain metastasis location on clinical outcomes: a review of the literature. Neuro-Oncology Adv. 2019;1:vdz017.","journal-title":"Neuro-Oncology Adv"},{"key":"1566_CR6","first-page":"2892","volume":"5","author":"A Midha","year":"2015","unstructured":"Midha A, Dearden S, McCormack R. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII). Am J Cancer Res. 2015;5:2892.","journal-title":"Am J Cancer Res"},{"key":"1566_CR7","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.3390\/cancers14143337","volume":"14","author":"A Koulouris","year":"2022","unstructured":"Koulouris A, Tsagkaris C, Corriero AC, Metro G, Mountzios G. Resistance to TKIs in EGFR-mutated non-small cell lung cancer: from mechanisms to new therapeutic strategies. Cancers (Basel). 2022;14:3337.","journal-title":"Cancers (Basel)"},{"key":"1566_CR8","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/cam4.673","volume":"5","author":"T Jiang","year":"2016","unstructured":"Jiang T, Min W, Li Y, Yue Z, Wu C, Zhou C. Radiotherapy plus EGFR TKIs in non-small cell lung cancer patients with brain metastases: an update meta\u2010analysis. Cancer Med. 2016;5:1055\u201365.","journal-title":"Cancer Med"},{"key":"1566_CR9","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1200\/JCO.2014.58.1736","volume":"33","author":"CK Lee","year":"2015","unstructured":"Lee CK, Wu Y-L, Ding PN, Lord SJ, Inoue A, Zhou C, et al. Impact of specific epidermal growth factor receptor (EGFR) mutations and clinical characteristics on outcomes after treatment with EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR-mutant lung cancer: a meta-analysis. J Clin Oncol. 2015;33:1958\u201365.","journal-title":"J Clin Oncol"},{"key":"1566_CR10","doi-asserted-by":"crossref","unstructured":"Fan Y, Huang Z, Fang L, Miu L, Lin N, Gong L et al. Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients. Onco Targets Ther 2013:1789\u2013803.","DOI":"10.2147\/OTT.S52172"},{"key":"1566_CR11","doi-asserted-by":"publisher","first-page":"e0228925","DOI":"10.1371\/journal.pone.0228925","volume":"15","author":"H-Y Yoon","year":"2020","unstructured":"Yoon H-Y, Ryu J-S, Sim YS, Kim D, Lee SY, Choi J, et al. Clinical significance of EGFR mutation types in lung adenocarcinoma: a multi-centre Korean study. PLoS ONE. 2020;15:e0228925.","journal-title":"PLoS ONE"},{"key":"1566_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5301\/ijbm.5000256","volume":"33","author":"R Biaoxue","year":"2018","unstructured":"Biaoxue R, Shuanying Y. Tissue or blood: which is more suitable for detection of EGFR mutations in non-small cell lung cancer? Int J Biol Markers. 2018;33:40\u20138.","journal-title":"Int J Biol Markers"},{"key":"1566_CR13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1177\/1758834017736252","volume":"9","author":"R Di Lorenzo","year":"2017","unstructured":"Di Lorenzo R, Ahluwalia MS. Targeted therapy of brain metastases: latest evidence and clinical implications. Ther Adv Med Oncol. 2017;9:781\u201396.","journal-title":"Ther Adv Med Oncol"},{"key":"1566_CR14","doi-asserted-by":"publisher","first-page":"854402","DOI":"10.3389\/fonc.2022.854402","volume":"12","author":"S Rubino","year":"2022","unstructured":"Rubino S, Oliver DE, Tran ND, Vogelbaum MA, Forsyth PA, Yu H-HM, et al. Improving brain metastases outcomes through therapeutic synergy between stereotactic radiosurgery and targeted cancer therapies. Front Oncol. 2022;12:854402.","journal-title":"Front Oncol"},{"key":"1566_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.crad.2022.08.149","volume":"78","author":"C McCague","year":"2023","unstructured":"McCague C, Ramlee S, Reinius M, Selby I, Hulse D, Piyatissa P, et al. Introduction to radiomics for a clinical audience. Clin Radiol. 2023;78:83\u201398. https:\/\/doi.org\/10.1016\/j.crad.2022.08.149.","journal-title":"Clin Radiol"},{"key":"1566_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2967\/jnumed.118.222893","volume":"61","author":"ME Mayerhoefer","year":"2020","unstructured":"Mayerhoefer ME, Materka A, Langs G, H\u00e4ggstr\u00f6m I, Szczypi\u0144ski P, Gibbs P, et al. Introduction to Radiomics. J Nucl Med. 2020;61:488\u201395. https:\/\/doi.org\/10.2967\/jnumed.118.222893.","journal-title":"J Nucl Med"},{"key":"1566_CR17","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1007\/s00330-021-08520-6","volume":"32","author":"Y Qi","year":"2022","unstructured":"Qi Y, Zhao T, Han M. The application of radiomics in predicting gene mutations in cancer. Eur Radiol. 2022;32:4014\u201324.","journal-title":"Eur Radiol"},{"key":"1566_CR18","doi-asserted-by":"publisher","unstructured":"Wang G, Wang B, Wang Z, Li W, Xiu J, Liu Z, et al. Radiomics signature of brain metastasis: prediction of EGFR mutation status. Eur Radiol 2021;31:4538\u201347. https:\/\/doi.org\/10.1007\/s00330-020-07614-x.","DOI":"10.1007\/s00330-020-07614-x"},{"key":"1566_CR19","doi-asserted-by":"publisher","unstructured":"Chen BT, Jin T, Ye N, Mambetsariev I, Wang T, Wong CW, et al. Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer. Front Oncol 2021;11. https:\/\/doi.org\/10.3389\/fonc.2021.621088.","DOI":"10.3389\/fonc.2021.621088"},{"key":"1566_CR20","doi-asserted-by":"crossref","unstructured":"Salameh J-P, Bossuyt PM, McGrath TA, Thombs BD, Hyde CJ, Macaskill P et al. Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist. Bmj 2020;370.","DOI":"10.1136\/bmj.m2632"},{"key":"1566_CR21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749\u201362. https:\/\/doi.org\/10.1038\/nrclinonc.2017.141.","journal-title":"Nat Rev Clin Oncol"},{"key":"1566_CR22","doi-asserted-by":"crossref","unstructured":"Tabnak P, HajiEsmailPoor Z, Baradaran B, Pashazadeh F, Maleki LA. MRI-Based Radiomics methods for Predicting Ki-67 expression in breast Cancer: a systematic review and Meta-analysis. Acad Radiol; 2023.","DOI":"10.1016\/j.acra.2023.10.010"},{"key":"1566_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529\u201336.","journal-title":"Ann Intern Med"},{"key":"1566_CR24","unstructured":"Guo J, Riebler A. meta4diag: bayesian bivariate meta-analysis of diagnostic test studies for routine practice. ArXiv Prepr ArXiv151206220 2015."},{"key":"1566_CR25","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/0194599817728898","volume":"157","author":"JJ Shin","year":"2017","unstructured":"Shin JJ, Zurakowski D. Null hypotheses, interval estimation, and bayesian analysis. Otolaryngol Neck Surg. 2017;157:919\u201320.","journal-title":"Otolaryngol Neck Surg"},{"key":"1566_CR26","doi-asserted-by":"publisher","unstructured":"Park YW, An C, Lee JS, Han K, Choi D, Ahn SS et al. Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer. Neuroradiology. 2021;63:343\u201352. https:\/\/doi.org\/10.1007\/s00234-020-02529-2","DOI":"10.1007\/s00234-020-02529-2"},{"key":"1566_CR27","doi-asserted-by":"publisher","unstructured":"Ahn SJ, Kwon H, Yang J-J, Park M, Cha YJ, Suh SH, et al. Contrast-enhanced T1-weighted image radiomics of brain metastases may predict EGFR mutation status in primary lung cancer. Sci Rep 2020;10:8905. https:\/\/doi.org\/10.1038\/s41598-020-65470-7.","DOI":"10.1038\/s41598-020-65470-7"},{"key":"1566_CR28","doi-asserted-by":"publisher","unstructured":"Cao R, Pang Z, Wang X, Du Z, Chen H, Liu J, et al. Radiomics evaluates the EGFR mutation status from the brain metastasis: a multi-center study. Phys Med Biol 2022;67.https:\/\/doi.org\/10.1088\/1361-6560\/ac7192.","DOI":"10.1088\/1361-6560\/ac7192"},{"key":"1566_CR29","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.21037\/qims-23-1744","volume":"14","author":"R Cao","year":"2024","unstructured":"Cao R, Fu L, Huang B, Liu Y, Wang X, Liu J, et al. Brain metastasis magnetic resonance imaging-based deep learning for predicting epidermal growth factor receptor (EGFR) mutation and subtypes in metastatic non-small cell lung cancer. Quant Imaging Med Surg. 2024;14:4749.","journal-title":"Quant Imaging Med Surg"},{"key":"1566_CR30","doi-asserted-by":"crossref","unstructured":"Huang Z, Tu X, Yu T, Zhan Z, Lin Q, Huang X. Peritumoural MRI radiomics signature of brain metastases can predict epidermal growth factor receptor mutation status in lung adenocarcinoma. Clin Radiol 2023.","DOI":"10.1016\/j.crad.2023.10.022"},{"key":"1566_CR31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.37349\/etat.2023.00158","volume":"4","author":"A Mahajan","year":"2023","unstructured":"Mahajan A, B G, Wadhwa S, Agarwal U, Baid U, Talbar S, et al. Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer. Explor Target Anti-Tumor Ther. 2023;4:657\u201368. https:\/\/doi.org\/10.37349\/etat.2023.00158.","journal-title":"Explor Target Anti-Tumor Ther"},{"key":"1566_CR32","doi-asserted-by":"publisher","unstructured":"Zheng L, Xie H, Luo X, Yang Y, Zhang Y, Li Y, et al. Radiomic Signatures for Predicting EGFR Mutation Status in Lung Cancer Brain Metastases. Front Oncol 2022;12. https:\/\/doi.org\/10.3389\/fonc.2022.931812.","DOI":"10.3389\/fonc.2022.931812"},{"key":"1566_CR33","doi-asserted-by":"publisher","unstructured":"Haim O, Abramov S, Shofty B, Fanizzi C, DiMeco F, Avisdris N, et al. Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastases. J Neurooncol 2022;157:63\u20139. https:\/\/doi.org\/10.1007\/s11060-022-03946-4.","DOI":"10.1007\/s11060-022-03946-4"},{"key":"1566_CR34","doi-asserted-by":"publisher","unstructured":"Fan Y, Zhao Z, Wang X, Ai H, Yang C, Luo Y, et al. Radiomics for prediction of response to EGFR-TKI based on metastasis\/brain parenchyma (M\/BP)-interface. Radiol Med 2022;127:1342\u201354. https:\/\/doi.org\/10.1007\/s11547-022-01569-3.","DOI":"10.1007\/s11547-022-01569-3"},{"key":"1566_CR35","doi-asserted-by":"publisher","unstructured":"Chen BT, Jin T, Ye N, Mambetsariev I, Daniel E, Wang T, et al. Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases. Magn Reson Imaging 2020;69:49\u201356. https:\/\/doi.org\/10.1016\/j.mri.2020.03.002.","DOI":"10.1016\/j.mri.2020.03.002"},{"key":"1566_CR37","doi-asserted-by":"publisher","first-page":"v52","DOI":"10.1093\/noajnl\/vdab106","volume":"3","author":"NJ Myall","year":"2021","unstructured":"Myall NJ, Yu H, Soltys SG, Wakelee HA, Pollom E. Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies. Neuro-Oncology Adv. 2021;3:v52\u201362.","journal-title":"Neuro-Oncology Adv"},{"key":"1566_CR38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fonc.2018.00208","volume":"8","author":"WJ Kelly","year":"2018","unstructured":"Kelly WJ, Shah NJ, Subramaniam DS. Management of brain metastases in epidermal growth factor receptor mutant non-small-cell lung cancer. Front Oncol. 2018;8:208.","journal-title":"Front Oncol"},{"key":"1566_CR39","doi-asserted-by":"crossref","unstructured":"Nguyen HS, Ho DKN, Nguyen NN, Tran HM, Tam K-W, Le NQK. Predicting EGFR Mutation Status in non\u2013small cell Lung Cancer using Artificial Intelligence: a systematic review and Meta-analysis. Acad Radiol; 2023.","DOI":"10.1016\/j.acra.2023.03.040"},{"key":"1566_CR40","doi-asserted-by":"crossref","unstructured":"Qin Q, Deng LP, Chen J, Ye Z, Wu YY, Yuan Y et al. The value of MRI in predicting hepatocellular carcinoma with cytokeratin 19 expression: a systematic review and meta-analysis. Clin Radiol 2023.","DOI":"10.1016\/j.crad.2023.08.013"},{"key":"1566_CR41","doi-asserted-by":"crossref","unstructured":"HajiEsmailPoor Z, Tabnak P, Baradaran B, Pashazadeh F, Aghebati Maleki L. Diagnostic performance of CT-Scan based Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer: a systematic review and Meta-analysis. Front Oncol n d;13:1185663.","DOI":"10.3389\/fonc.2023.1185663"},{"key":"1566_CR42","doi-asserted-by":"crossref","unstructured":"HajiEsmailPoor Z, Kargar Z, Tabnak P. Radiomics diagnostic performance in predicting lymph node metastasis of papillary thyroid carcinoma: a systematic review and meta-analysis. Eur J Radiol 2023:111129.","DOI":"10.1016\/j.ejrad.2023.111129"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01566-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01566-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01566-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T02:10:28Z","timestamp":1739239828000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01566-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1566"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01566-8","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}